About Pharmazell Group
Pharmazell Group is a company based in Raubling (Germany) founded in 1946 was acquired by Bridgepoint Capital in February 2020. Pharmazell Group operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Raubling, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
EQT
& 3 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pharmazell Group
Investors in Pharmazell Group
Pharmazell Group has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include EQT, Deutsche Private Equity and Bridgepoint Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Apheon is engaged in private equity investments across Europe.
|
Locked | Locked | Locked | |
|
EQT is recognized as a global investment organization focused on value creation.
|
Locked | Locked | Locked | |
|
Private equity firm
|
Locked | Locked | Locked |
Investor details for Pharmazell Group
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmazell Group
Investment portfolio details for Pharmazell Group
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pharmazell Group
Detailed financials for Pharmazell Group
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmazell Group Comparisons
Peer comparison for Pharmazell Group
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharmazell Group
Pharmazell Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Pharmazell Group
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmazell Group
Complete news archive for Pharmazell Group
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmazell Group
Pharmazell Group was founded in 1946 and raised its 1st funding round 61 years after it was founded.
Pharmazell Group is headquartered in Raubling, Germany. It is registered at Raubling, Bayern, Germany.
The Pharmazell Group was established in 1946 in Raubling, Germany, where active pharmaceutical ingredients are produced for the global pharmaceutical sector. Operations center on the development and manufacturing of APIs, with a focus on quality standards required by the industry. The company is directed by Managing Director Anant Barbadikar. Geographic emphasis remains on European facilities, supporting supply chains for international clients in drug formulation.
Pharmazell Group's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Pharmazell Group has 4 investors. Key investors include EQT, Deutsche Private Equity, Bridgepoint Capital, and Apheon.